Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 529 results found. Search for [ covid-19 human trials ]

Results 100 to 120 of 529
BusinessToday.In
November 18, 2020
The Chapare virus, named after the region where it was first observed, was discovered due to the ongoing efforts of scientists around the globe to avert future pandemics like COVID-19


BusinessToday.In
November 17, 2020
The approval to conduct Phase 2 and Phase 3 trials was granted to Dr Reddy's laboratory by the Drug Controller General of India (DCGI)


Manoj Sharma
November 17, 2020
Dr Ali Nouri, molecular biologist and President, Federation of American Scientists, has explained how these vaccine candidates work in simplest possible way on Twitter


Reuters
November 17, 2020
The Hyderabad-based firm initiated phase I and phase II trials of its vaccine candidate after getting the green signal from the Drugs Controller General of India


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


PTI
November 15, 2020
College principal R B Kamal said the effect of the vaccine on the volunteers will be studied for seven months after the same is administered once, twice or thrice within an interval of 21 day


Reuters
November 15, 2020
Under the agreement, the company will commit approximately $604 million and the US govt will commit about $454 million to support the Phase 3 clinical trial


BusinessToday.In
November 13, 2020
On nations hoarding vaccine stocks to meet their requirements first, Dmitriev said it is not about vaccine nationalism and that India is an important partner


PB Jayakumar
November 12, 2020
Covishield has been developed at the Serum Institute of India's Pune laboratory with a master seed from Oxford University/Astra Zeneca. The vaccine made in the UK is currently being tested in large efficacy trials in UK, Brazil, South Africa and USA


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


Anshula Raj
November 12, 2020
Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India


BusinessToday.In
November 11, 2020
Russia coronavirus vaccine: The interim trial results were announced by Russia's sovereign wealth fund Russian Direct Investment Fund on Wednesday. RDIF is backing the vaccine and marketing it globally


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 10, 2020
Sputnik V vaccine, developed by the Gamaleya National Research Institute of Epidemiology, was registered by the Russian Health Ministry


BusinessToday.In
November 4, 2020
COVID-19 vaccine update: Based on the success of the trials and regulatory approvals, we can expect vaccine to be available in India by January 2021, only if its proven immunogenic and efficacious, says SII CEO Adar Poonawalla


BusinessToday.In
November 4, 2020
Scientists have developed a vaccine candidate for COVID-19 that produces high levels of antibodies and better immune response in animals. J&J vaccine trials have resumed in Brazil and Mexico has received coronavirus vaccine from CanSino Biologics for late-stage trials


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


Reuters
October 29, 2020
While the company did not give a clear timeline on the release of data from these trials on Thursday, it has said that early data is expected in the coming weeks


PTI
October 29, 2020
On August 11, 2020, the Sputnik V vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology was registered by the Ministry of Health of Russia


BusinessToday.In
October 29, 2020
Dr Reddy's and Russian Direct Investment Fund (RDIF) joined hands to carry out clinical trials and distribute 100 million doses of Sputnik V vaccine across India


PAGES 6 OF 27  678910